Spago Nanomedical AB (publ) (FRA:7UX)
Germany flag Germany · Delayed Price · Currency is EUR
0.0102
+0.0004 (4.08%)
At close: Feb 20, 2026

Spago Nanomedical AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
29.6732.4745.2262.152.46
Cash & Short-Term Investments
29.6732.4745.2262.152.46
Cash Growth
-8.62%-28.19%-27.19%18.38%84.41%
Accounts Receivable
-0.20.370.050.04
Other Receivables
0.124.463.580.660.86
Receivables
0.124.663.950.710.89
Prepaid Expenses
5.351.462.742.431.03
Other Current Assets
0.8-0-0--
Total Current Assets
35.9438.5951.9165.2454.39
Property, Plant & Equipment
0.140.610.930.851.08
Long-Term Investments
---0-
Other Intangible Assets
---8.117.31
Long-Term Deferred Charges
---131.74128.85
Other Long-Term Assets
0.610.380.15-0-
Total Assets
36.6839.5852.99205.95191.62
Accounts Payable
3.162.726.394.733.86
Accrued Expenses
1.731.821.531.561.49
Other Current Liabilities
0.271.323.562.511.47
Total Current Liabilities
5.175.8611.488.86.81
Pension & Post-Retirement Benefits
0.610.380.15--
Other Long-Term Liabilities
0.160.10.04--
Total Liabilities
5.946.3511.678.86.81
Common Stock
6.623.4818.8690.9441.18
Additional Paid-In Capital
303.4282.1270.56257.15255.37
Retained Earnings
----150.93-111.74
Comprehensive Income & Other
-279.27-252.35-248.1--
Total Common Equity
30.7533.2441.32197.16184.81
Shareholders' Equity
30.7533.2441.32197.16184.81
Total Liabilities & Equity
36.6839.5852.99205.95191.62
Net Cash (Debt)
29.6732.4745.2262.152.46
Net Cash Growth
-8.62%-28.19%-27.19%18.38%84.41%
Net Cash Per Share
0.080.110.460.971.33
Filing Date Shares Outstanding
661.57348.2219.5190.9441.18
Total Common Shares Outstanding
661.57348.2219.5190.9441.18
Working Capital
30.7732.7240.4356.4547.58
Book Value Per Share
0.050.100.192.174.49
Tangible Book Value
30.7533.2441.32189.04177.5
Tangible Book Value Per Share
0.050.100.192.084.31
Machinery
-4.274.84.454.31
Source: S&P Global Market Intelligence. Standard template. Financial Sources.